Vanguard Group’s VolitionRx Ltd VNRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $392K | Hold |
76,502
| – | – | ﹤0.01% | 3990 |
|
|
2025
Q3 | $1.04M | Sell |
76,502
-4,735
| -6% | -$63K | ﹤0.01% | 3778 |
|
|
2025
Q2 | $1.23M | Buy |
81,237
+45,934
| +130% | +$506K | ﹤0.01% | 3685 |
|
|
2025
Q1 | $402K | Buy |
35,303
+3,470
| +11% | +$41.4K | ﹤0.01% | 3927 |
|
|
2024
Q4 | $382K | Hold |
31,833
| – | – | ﹤0.01% | 3999 |
|
|
2024
Q3 | $383K | Hold |
31,833
| – | – | ﹤0.01% | 4038 |
|
|
2024
Q2 | $385K | Buy |
31,833
+25
| +0.1% | +$366 | ﹤0.01% | 4065 |
|
|
2024
Q1 | $482K | Buy |
31,808
+326
| +1% | +$6.39K | ﹤0.01% | 4016 |
|
|
2023
Q4 | $451K | Buy |
31,482
+4,360
| +16% | +$64.1K | ﹤0.01% | 4071 |
|
|
2023
Q3 | $374K | Buy |
27,122
+1,102
| +4% | +$27.3K | ﹤0.01% | 4138 |
|
|
2023
Q2 | $723K | Buy |
26,020
+720
| +3% | +$23.7K | ﹤0.01% | 4001 |
|
|
2023
Q1 | $966K | Buy |
25,300
+100
| +0.4% | +$4.18K | ﹤0.01% | 3930 |
|
|
2022
Q4 | $1.22M | Buy |
25,200
+36
| +0.1% | +$1.4K | ﹤0.01% | 3840 |
|
|
2022
Q3 | $685K | Hold |
25,164
| – | – | ﹤0.01% | 4121 |
|
|
2022
Q2 | $1.03M | Hold |
25,164
| – | – | ﹤0.01% | 4075 |
|
|
2022
Q1 | $1.51M | Sell |
25,164
-315
| -1% | -$17.9K | ﹤0.01% | 4067 |
|
|
2021
Q4 | $1.6M | Sell |
25,479
-109
| -0.4% | -$7.44K | ﹤0.01% | 4122 |
|
|
2021
Q3 | $1.59M | Buy |
25,588
+634
| +3% | +$40.2K | ﹤0.01% | 4129 |
|
|
2021
Q2 | $1.64M | Sell |
24,954
-6,802
| -21% | -$460K | ﹤0.01% | 4024 |
|
|
2021
Q1 | $2.4M | Buy |
31,756
+8,847
| +39% | +$759K | ﹤0.01% | 3825 |
|
|
2020
Q4 | $1.78M | Sell |
22,909
-321
| -1% | -$22.1K | ﹤0.01% | 3694 |
|
|
2020
Q3 | $1.49M | Buy |
23,230
+1,610
| +7% | +$109K | ﹤0.01% | 3570 |
|
|
2020
Q2 | $1.68M | Buy |
21,620
+5,557
| +35% | +$401K | ﹤0.01% | 3478 |
|
|
2020
Q1 | $1M | Hold |
16,063
| – | – | ﹤0.01% | 3493 |
|
|
2019
Q4 | $1.52M | Hold |
16,063
| – | – | ﹤0.01% | 3524 |
|
|
2019
Q3 | $1.8M | Buy |
16,063
+114
| +0.7% | +$9.08K | ﹤0.01% | 3486 |
|
|
2019
Q2 | $1M | Hold |
15,949
| – | – | ﹤0.01% | 3677 |
|
|
2019
Q1 | $1.04M | Hold |
15,949
| – | – | ﹤0.01% | 3622 |
|
|
2018
Q4 | $577K | Buy |
15,949
+1,061
| +7% | +$50.5K | ﹤0.01% | 3708 |
|
|
2018
Q3 | $771K | Hold |
14,888
| – | – | ﹤0.01% | 3778 |
|
|
2018
Q2 | $596K | Buy |
14,888
+20
| +0.1% | +$894 | ﹤0.01% | 3795 |
|
|
2018
Q1 | $714K | Buy |
14,868
+4,618
| +45% | +$270K | ﹤0.01% | 3726 |
|
|
2017
Q4 | $603K | Hold |
10,250
| – | – | ﹤0.01% | 3704 |
|
|
2017
Q3 | $540K | Hold |
10,250
| – | – | ﹤0.01% | 3730 |
|
|
2017
Q2 | $725K | Hold |
10,250
| – | – | ﹤0.01% | 3648 |
|
|
2017
Q1 | $824K | Buy |
10,250
+115
| +1% | +$10.2K | ﹤0.01% | 3630 |
|
|
2016
Q4 | $927K | Buy |
10,135
+8,219
| +429% | +$737K | ﹤0.01% | 3577 |
|
|
2016
Q3 | $203K | Buy |
+1,916
| New | +$149K | ﹤0.01% | 3900 |
|
Other funds holding VNRX
LIM
SBCM
VF
Vanguard Group's VNRX Position: Q4 2025 in Review
Vanguard Group held its VolitionRx Ltd (VNRX) position steady in Q4 2025 at 76,502 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #3990.
Vanguard Group first reported a position in VNRX in Q3 2016 and has held it in 38 quarters since. The position peaked at $2.4M in Q1 2021. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2025.
- Vanguard Group held 76,502 shares of VolitionRx Ltd worth $392K as of Q4 2025.
- Vanguard Group left its VolitionRx Ltd share count unchanged in Q4 2025.
- VolitionRx Ltd made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3990 holding.
- Vanguard Group first reported a position in VolitionRx Ltd in Q3 2016 and has held it in 38 quarters since.
- Vanguard Group's VolitionRx Ltd position peaked at $2.4M in Q1 2021.
- 28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.